Structure-based drug design meets the ribosome
- 26 January 2006
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 71 (7), 1016-1025
- https://doi.org/10.1016/j.bcp.2005.12.026
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Emergence of Resistance to Daptomycin during Treatment of Vancomycin-Resistant Enterococcus faecalis InfectionClinical Infectious Diseases, 2005
- Daptomycin – a novel antibiotic against Gram-positive pathogensExpert Opinion on Pharmacotherapy, 2004
- Structure-Based Design, Synthesis, and Structure−Activity Relationship Studies of Novel Non-nucleoside Adenosine Deaminase InhibitorsJournal of Medicinal Chemistry, 2004
- Design, Parallel Synthesis, and Crystal Structures of Pyrazinone Antithrombotics as Selective Inhibitors of the Tissue Factor VIIa ComplexJournal of Medicinal Chemistry, 2003
- Linezolid Resistance since 2001: SENTRY Antimicrobial Surveillance ProgramAnnals of Pharmacotherapy, 2003
- Linezolid resistance in a clinical isolate of Staphylococcus aureusThe Lancet, 2001
- Molecular mechanisms that confer antibacterial drug resistanceNature, 2000
- L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease InhibitorJournal of Medicinal Chemistry, 1994
- Design, Activity, and 2.8 Å Crystal Structure of a C 2 Symmetric Inhibitor Complexed to HIV-1 ProteaseScience, 1990
- Rational Design of Peptide-Based HIV Proteinase InhibitorsScience, 1990